Evaluation of ticlopidine, a novel inhibitor of platelet aggregation, in heart transplant recipients. 1993

M de Lorgeril, and P Boissonnat, and G Dureau, and J Guidollet, and S Renaud
INSERM U.63, Laboratory of Biochemistry, Hôpital Cardiologique, Lyon, France.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013988 Ticlopidine An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES. 53-32C,Ticlid,Ticlodix,Ticlodone,Ticlopidine Hydrochloride,53 32C,5332C,Hydrochloride, Ticlopidine

Related Publications

M de Lorgeril, and P Boissonnat, and G Dureau, and J Guidollet, and S Renaud
July 1992, Clinical pharmacy,
M de Lorgeril, and P Boissonnat, and G Dureau, and J Guidollet, and S Renaud
January 1979, Archivio "E. Maragliano" di patologia e clinica,
M de Lorgeril, and P Boissonnat, and G Dureau, and J Guidollet, and S Renaud
October 1975, Clinical pharmacology and therapeutics,
M de Lorgeril, and P Boissonnat, and G Dureau, and J Guidollet, and S Renaud
June 1978, Thrombosis research,
M de Lorgeril, and P Boissonnat, and G Dureau, and J Guidollet, and S Renaud
November 1984, La Clinica terapeutica,
M de Lorgeril, and P Boissonnat, and G Dureau, and J Guidollet, and S Renaud
March 1984, Clinical nephrology,
M de Lorgeril, and P Boissonnat, and G Dureau, and J Guidollet, and S Renaud
April 2004, Clinical transplantation,
M de Lorgeril, and P Boissonnat, and G Dureau, and J Guidollet, and S Renaud
May 1987, Kyobu geka. The Japanese journal of thoracic surgery,
M de Lorgeril, and P Boissonnat, and G Dureau, and J Guidollet, and S Renaud
January 1980, Arzneimittel-Forschung,
M de Lorgeril, and P Boissonnat, and G Dureau, and J Guidollet, and S Renaud
May 1989, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!